Citation Impact

Citing Papers

Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
2008
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
Evolution of the Cancer Stem Cell Model
2014 Standout
Head and neck squamous cell carcinoma
2020 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells
2010
Carcinogenesis of Helicobacter pylori
2007
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy
2009
Combined hepatocellular-cholangiocarcinoma: An update
2021
Expression of Multidrug Resistance Genes in Normal and Cancer Stem Cells
2008
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
2007
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
The cancer stem cell: premises, promises and challenges
2011 Standout
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
2007
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
Hepatocellular carcinoma
2022 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Gut Microbiota in Health and Disease
2010 Standout
Targeted CML therapy: controlling drug resistance, seeking cure
2005
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
2021

Works of Yang Ou being referenced

Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC)
2020
[Tumor stem cells and drug resistance].
2007
Rankless by CCL
2026